Document:

Converted by EDGARwiz

Exhibit 10.3.1

ISO AGREEMENT

THIS AGREEMENT, entered into as of the Grant Date (as defined in paragraph 1), by and between the Participant and Greenway Medical Technologies
Inc. (the “Company”);

WITNESSETH THAT:

WHEREAS, the Company maintains the 1999 Stock Option Plan (the “Plan”), which is incorporated into and forms a part of this Agreement, and the
Participant has been selected by the committee administering the Plan (the “Committee”) to receive a Qualified Stock Option Award under the Plan;

NOW, THEREFORE, IT IS AGREED, by and between the Company and the Participant, as follows:

1.  Terms of Award.  For following terms used in this Agreement shall have the meanings set forth in this paragraph 1:

(a)

The “Participant” is [Name].

(b)

The “Grant Date” is [Date].

(c)

The number of “Covered Shares” shall be [Shares] shares of Stock.

(d)

The “Exercise Price” is $ [Strike] per share.

Other terms used in this Agreement are defined pursuant to paragraph 8 or elsewhere in this Agreement.

2.  Award and Exercise Price.  This Agreement specifies the terms of the option (the “Option”) granted to the Participant to
purchase the number of Covered Shares of Stock at the Exercise Price per share as set forth in paragraph 1. The Option is intended to constitute an “incentive stock option” as that term is used in Code section 422. To the extent that the
aggregate fair market value (determined at the time of grant) of Shares with respect to which incentive stock options are exercisable for the first time by the Participant during any calendar year under all plans of the Company and its Affiliates exceeds
$100,000, the options or portions thereof which exceed such limit (according to the order in should be understood that there is no assurance that the option will, in fact, be treated as an incentive stock option.

3.  Date of Exercise. Subject to the limitations of this Agreement, the Option shall be exercisable according
to the following schedule, with respect to each installment shown in the schedule on and after the Vesting Date applicable to such installment:

		
	INSTALLMENT

	VESTING DATE APPLICABLE
TO
INSTALLMENT

	1/5 of Covered Shares

	[date]

	1/5 of Covered Shares

	[date]

	1/5 of Covered Shares

	[date]

	1/5 of Covered Shares

	[date]

	1/5 of Covered Shares

	[date]

An Installment shall not become exercisable on the otherwise applicable Vesting Date until the earliest to occur of the following:

(a)  the tenth anniversary of the Option grant; or 

(b)  an initial public offering of the Common Stock.  

An Installment shall not become exercisable on the otherwise applicable Vesting Date if the Participant’s Date of Termination (as defined in paragraph 8) occurs on or
before such Vesting Date. Notwithstanding the foregoing provisions of this paragraph 3, the Option shall become exercisable with respect to all of the Covered Shares (to the extent it is not then otherwise exercisable) as follows:

(a)

The Option shall become fully exercisable upon the Participant’s Date of Termination, if the Participant’s Date of Termination occurs by reason
of the Participant’s death or Normal Retirement.

(b)

The Option shall become fully exercisable upon a Change in Control and the Constructive Termination of the Participant, if the Participant’s Date of
Termination does not occur on or before the Change in Control.

(c)

Otherwise, the Option shall become fully exercisable one year after the Change in Control, provided the Participant remains an employee of the Company.

The Option may be exercised on or after the Date of Termination only as to that portion of the Covered Shares as to which it was exercisable immediately prior to 

the Date of Termination, or as to which it became exercisable on the Date of Termination in accordance with this paragraph 3.

4.  Expiration.  The Option shall not be exercisable after the Company’s close of business on the last business day that occurs prior
to the Expiration Date. The “Expiration Date” shall be earliest to occur of:

(a)

the ten-year anniversary of the Grant Date;

(b)

if the Participant’s Date of Termination occurs by reason of death, the one-year anniversary of such Date of Termination;

(c)

if the Participant’s Date of Termination occurs by reason of disability, the 90-day anniversary of such Date of Termination; 

(d)

if the Participant’s Date of Termination occurs by reason of Cause, the options expire on the Date of Termination; or

(e)

if the Participant’s Date of Termination occurs for reasons other than death, Disability or Cause, the 30-day anniversary of such Date of Termination.

5.  Method of Option Exercise.  Subject to the Agreement and the Plan, the Option may be exercised in whole or in part; provided, that no
partial exercise of an Option shall be for an aggregate number of less than 100 Options. An Option shall be exercised by delivering notice to the Company's principal office, to the attention of its Plan Administrator, no less than one business day in
advance of the effective date of the proposed exercise. Such notice shall specify the number of shares of Stock which the Participant elects to purchase, and shall be accompanied by payment of the Exercise Price for such shares of Stock indicated
by the Participant’s election. Payment shall be by cash or by check payable to the Company. Except as otherwise provided by the Committee before the Option is exercised: (i) all or a portion of the Exercise Price may be paid by the Participant
by either actual delivery of shares or by attestation, mature shares of Company Stock owned by the Participant (for a minimum of six months) and valued at their Fair Market Value on the effective date of such exercise, or partly in shares of Company Stock with
the balance in cash, by certified check, bank cashier's check or wire transfer; and (ii) the Participant may pay the Exercise Price by authorizing a third party to sell shares of Stock (or a sufficient portion of the shares) acquired upon exercise of the
Option and remit to the Company a sufficient portion of the sale proceeds to pay the entire Exercise Price and any tax withholding resulting from such exercise. The Option shall not be exercisable if and to the extent the Company determines that such
exercise would violate 

applicable state or Federal securities laws or the rules and regulations of any securities exchange on which the Stock is traded. If the Company makes such a determination,
it shall use all reasonable efforts to obtain compliance with such laws, rules or regulations. In making any determination hereunder, the Company may rely on the opinion of counsel for the Company.

6.  Withholding.  All deliveries and distributions under this Agreement are subject to withholding of all applicable taxes. At the election of
the Participant, and subject to such rules and limitations as may be established by the Committee from time to time, such withholding obligations may be satisfied through the surrender of shares of Stock which the Participant already owns, or to which the
Participant is otherwise entitled under the Plan.

7.  Transferability.  The Option is not transferable other than as designated by the Participant by will or by the laws of descent and
distribution, and during the Participant’s life, may be exercised only by the Participant.

8.  Definitions.  For purposes of this Agreement, the terms used in this Agreement shall be subject to the following:

(a)

Change in Control.  The term “Change in Control” means:

(i)

Change in the ownership of the Company

(a) Any one person, or more than one person acting as a group, acquires ownership of stock of the Company that, together with stock held by such person or
group, possesses more than 50 percent of the total fair market value or total voting power of the stock of the Company. However, if any one person, or more than one person acting as a group, is considered to own more than 50 percent of the total fair
market value or total voting power of the Company's stock, the acquisition of additional stock by the same person or persons is not considered to cause a change in the ownership of the Company (or to cause a change in the effective control of the corporation
(within the meaning of paragraph (b) of section 2(ii))). An increase in the percentage of stock owned by any one person, or persons acting as a group, as a result of a transaction in which the Company acquires its stock in exchange for property will be
treated as an acquisition of stock for purposes of this section;

ii)

Change in the effective control of the Company

(a) Any one person, or more than one person acting as a group, acquires (or has acquired during the 12 month period ending on the date of the most recent
acquisition by such person or persons) ownership of stock of the corporation possessing 50 percent or more of the total voting power of the stock of such corporation; or 

(b) A majority of members of the Company's Board of Directors is replaced during any 12-month period by directors whose appointment or election is not
endorsed by a majority of the members of the Company's Board of Directors prior to the date of the appointment or election. This presumption may be rebutted by establishing that such acquisition or acquisitions of the Company's stock, or such
replacement of the majority of the members of the Company's Board of Directors, does not transfer the power to control (directly or indirectly) the management and policies of the Company from any one person (or more than one person acting as a group)
to another person (or group). For purposes of this section, in the absence of an event described in paragraph (a) or (b) of section (ii), a change in the effective control of the Company is presumed not to have occurred.

(c) If any one person, or more than one person acting as a group, is considered to effectively control a corporation (within the meaning of section (ii)),
the acquisition of additional control of the Company by the same person or persons is not considered to cause a change in the effective control of the Company (or to cause a change in the ownership of the Company within the meaning of paragraph (i) of this
section);

(iii)

Change in ownership of a substantial portion of the Company's assets

(a) Any one person, or more than one person acting as a group, acquires (or has acquired during the 12-month period ending on the date of the most recent
acquisition by such person or persons) assets from the Company that have a total fair market value equal to or more than one third of the total fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions.

(b) A transfer of assets by the Company is not treated as a change in the ownership of such assets if the assets are transferred to: (1) a shareholder of
the Company (immediately before the asset transfer) in exchange for or with respect to its stock, (2) an entity, 50 percent 

or more of the total value or voting power of which is owned, directly or indirectly, by the Company, (3) a person, or more than one person acting as a group, that owns,
directly or indirectly, 50 percent or more of the total value or voting power of all the outstanding stock of the Company, or (4) an entity, at least 50 percent of the total value or voting power is owned, directly or indirectly, by a person described in
paragraph (b)(3) of section 2(d)(iii).

(b)

Date of Termination.  The Participant’s “Date of Termination” shall be the first day occurring on or after
the Grant Date on which the Participant is not employed by the Company or any Subsidiary, regardless of the reason for the termination of employment; provided that a termination of employment shall not be deemed to occur by reason of a transfer of the
Participant between the Company and a Subsidiary or between two Subsidiaries; and further provided that the Participant’s employment shall not be considered terminated while the Participant is on a leave of absence from the Company or a Subsidiary
approved by the Participant’s employer. If, as a result of a sale or other transaction, the Participant’s employer ceases to be a Subsidiary (and the Participant’s employer is or becomes an entity that is separate from the Company),
the occurrence of such transaction shall be treated as the Participant’s Date of Termination caused by the Participant being discharged by the employer.

(c)

Disability.  Except as otherwise provided by the Committee, the Participant shall be considered to have a “Disability”
during the period in which the Participant is unable, by reason of a medically determinable physical or mental impairment, to engage in any substantial gainful activity, which condition, in the opinion of a physician selected by the Committee, is expected to
have a duration of not less than 120 days.

(d)

Retirement.  “Retirement” of the Participant shall mean, with the approval of the Committee, the occurrence of
the Participant’s Date of Termination on or after the date the Participant attains age 65.

(e)

Plan Definitions.  Except where the context clearly implies or indicates the contrary, a word, term, or phrase used in the
Plan is similarly used in this Agreement.

9.  Heirs and Successors.  This Agreement shall be binding upon, and inure to the benefit of, the Company and its successors and assigns,
and upon any person acquiring, whether by merger, consolidation, purchase of assets or otherwise, all or substantially all of the Company’s assets and business. If any rights exercisable by the Participant or benefits deliverable to the Participant
under this Agreement have not been exercised or delivered, respectively, at the time of the Participant’s death, such rights shall be exercisable by the Designated Beneficiary, and such benefits shall be delivered to the Designated Beneficiary, in
accordance with the provisions of this Agreement and the Plan. The “Designated Beneficiary” shall be the beneficiary or beneficiaries designated by the Participant in a writing filed with the Committee in such form and at such time as the
Committee shall require. If a deceased Participant fails to designate a beneficiary, or if the Designated Beneficiary does not survive the Participant, any rights that would have been exercisable by the Participant and any benefits distributable to
the Participant shall be exercised by or distributed to the legal representative of the estate of the Participant. If a deceased Participant designates a beneficiary but the Designated Beneficiary dies before the Designated Beneficiary’s exercise
of all rights under this Agreement or before the complete distribution of benefits to the Designated Beneficiary under this Agreement, then any rights that would have been exercisable by the Designated Beneficiary shall be exercised by the legal
representative of the estate of the Designated Beneficiary, and any benefits distributable to the Designated Beneficiary shall be distributed to the legal representative of the estate of the Designated Beneficiary.

10.  Administration.  The authority to manage and control the operation and administration of this Agreement shall be vested in the
Committee, and the Committee shall have all powers with respect to this Agreement as it has with respect to the Plan. Any interpretation of the Agreement by the Committee and any decision made by it with respect to the Agreement is final and
binding on all persons.

11.  Plan Governs.  Notwithstanding anything in this Agreement to the contrary, the terms of this Agreement shall be subject to the terms
of the Plan, a copy of which may be obtained by the Participant from the Plan Administrator; and this Agreement is subject to all interpretations, amendments, rules and regulations promulgated by the Committee from time to time pursuant to the Plan.

12.  Not An Employment Contract.  The Option will not confer on the Participant any right with respect to continuance of employment or
other service with the Company or any Subsidiary, nor will it interfere in any way with any 

right the Company or any Subsidiary would otherwise have to terminate or modify the terms of such Participant’s employment or other service at any time.

13.  Notices.  Any written notices provided for in this Agreement or the Plan shall be in writing and shall be deemed sufficiently given
if either hand delivered or if sent by fax or overnight courier, or by postage paid first class mail. Notices sent by mail shall be deemed received three business days after mailed but in no event later than the date of actual receipt. Notices shall
be directed, if to the Participant, at the Participant’s address indicated by the Company’s records, or if to the Company, at the Company’s principal executive office.

14.  Fractional Shares.  In lieu of issuing a fraction of a share upon any exercise of the Option, resulting from an adjustment of the
Option pursuant to paragraph 4.2(e) of the Plan or otherwise, the Company will be entitled to pay to the Participant an amount equal to the fair market value of such fractional share.

15.  No Rights As Shareholder.  The Participant shall not have any rights of a shareholder with respect to the shares subject to the
Option, until a stock certificate has been duly issued following exercise of the Option as provided herein.

16.  Buy-Sell Agreement.  Any stock acquired pursuant to this agreement is subject to the Corporate Buy-Sell Agreement Between Stockholders.

[17.  Adjustments for Pooling-of-Interests Accounting.  If the Company enters into a transaction which is intended to be accounted for
using the pooling-of-interests method of accounting, but it is determined by the Board that the Option or any aspect thereof could reasonably be expected to preclude such treatment, then the Board may modify (to the minimum extent required) or revoke
(if necessary) the Option or any of the provisions thereof to the extent that the Board determines that such modification or revocation is necessary to enable the transaction to be subject to pooling-of-interests accounting.]

18.  Amendment.  This Agreement may be amended by written Agreement of the Participant and the Company, without the consent of any other person.

IN WITNESS WHEREOF, the Participant has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf,
all as of the Grant Date.

Participant

                                        

 Greenway Medical Technologies, Inc.

By:                                     

Its:Converted by EDGARwiz

Exhibit 10.3.2

 

NON-QUALIFIED STOCK OPTION AGREEMENT

THIS OPTION AGREEMENT, made this [________], between Greenway Medical Technologies, Inc., a Georgia corporation (the "Corporation"), and [________]
("Grantee");

WITNESSETH THAT:

WHEREAS, the Corporation maintains the “1999 Stock Option Plan” (the “Plan”), which is incorporated into and forms a part of this Agreement, and the Grantee has
been selected by the committee administering the Plan (the “Committee”) to receive a Non-Qualified Stock Option Award under the Plan;

NOW, THEREFORE, in consideration of the mutual covenants hereinafter set forth and for other good and valuable consideration, the parties hereto agree as follows:

1.

Grant of option. The Corporation hereby irrevocably grants to the Grantee the right and option, hereinafter called the Option, to purchase all or any part of an
aggregate of [________] Common Shares (such number being subject to adjustment as provided in paragraph 6 hereof) on the terms and conditions herein set forth. 

2.

Purchase price; Exercise. The purchase price of the Common Shares covered by the Option shall be [________]. This option and any portion thereof,
may be exercised only upon the happening of any of the following events:

A.

All or substantially all of the Corporation’s common stock is converted into or exchanged for corporate equity interests which are listed and actively traded on a recognized
stock exchange; or

B.

Ten (10) years from the date of this Option Agreement.

3.

Term of option. The term of the Option shall be for a period of ten years from the date hereof, subject to earlier termination as provided herein. The purchase price
of the shares as to which the Option shall be exercised shall be paid in full in cash at the time of exercise. The holder of the Option shall not have any of the rights of a shareholder with respect to the shares covered by the Option except to the extent
that one or more certificates for such shares shall be delivered to him upon the due exercise of the Option.

4.

Nontransferability. The Option shall not be transferable otherwise than by will or the laws of descent and distribution, and the Option may be exercised,
during the lifetime of the Grantee, only by him. More particularly (but without limiting the generality of the foregoing), the Option may not be assigned, transferred (except as provided above), pledged, or hypothecated in any way, shall not be
assignable by operation of law, and shall not be subject to execution, attachment, or similar process. Any attempted assignment, transfer, pledge, hypothecation, or other disposition of the Option contrary to the provisions hereof, and the levy of any
execution, attachment, or similar process upon the Option, shall be null and void and without effect and shall operate to terminate the Option and to divest Grantee of same.

5.

Death of Grantee.  If the Grantee shall die prior to a date on which this Option becomes exercisable, the Option may be exercised (to the extent that the Grantee
shall have been entitled to do so at the date of his death) by a legatee or legatees of the Grantee under his last will, or by his personal representatives or distributees, at any time within three years after his death, but not more than ten years after
the date hereof. 

6.

Changes in capital structure. If all or any portion of the Option shall be exercised subsequent to any share dividend, split-up, recapitalization, merger, consolidation,
combination or exchange of shares, separation, reorganization, or liquidation occurring after the date hereof, as a result of which shares of any class shall be issued in respect of outstanding Common Shares or Common Shares shall be changed into the same
or a different number of shares of the same or another class or classes, the person or persons so exercising the Option shall receive, for the aggregate price paid upon such exercise, the aggregate number and class of shares which, if Common Shares (as
authorized at the date hereof) had been purchased at the date hereof for the same aggregate price (on the basis of the price per share set forth in paragraph 2 hereof) and had not been disposed of, such person or persons would be holding, at the time of
such exercise, as a result of such purchase and all such share dividends, split-ups, recapitalizations, mergers, consolidations, combinations or exchanges of shares, separations, reorganizations, or liquidations; provided, however, that no fractional
share shall be issued upon any such exercise, and the aggregate price paid shall be appropriately reduced on account of any fractional share not issued.

7.

Limitations. This Option may not be exercised if such exercise would constitute a violation of any applicable Federal or State securities or other law or valid
regulation. The Grantee, as a condition to his exercise of this Option, shall represent to the Corporation that the shares that he acquires under this Option are being acquired by him for investment and not with a present view to distribution or resale,
unless counsel for the Corporation is then of the opinion that such a representation is not required under the Securities Act of 1933 or any other applicable law, regulation, or rule of any governmental agency.

8.

Method of exercising option.  Subject to the terms and conditions of this Option, the Option may be exercised by written notice to the Corporation’s legal
counsel,
William G. Esslinger, Jr., 121 Greenway Blvd., Carrollton, Georgia, 30117 (phone: 770-836-3100). Such notice shall state the election to exercise the Option and the number of shares in respect of which it is being exercised, and shall be signed by the
person or persons so exercising the Option. Upon receipt of such notice, accompanied by payment of the full purchase price of such shares and the original, signed draft of this Option, the Corporation’s counsel shall deliver to Grantee a certificate or
certificates representing such shares and a new option for those shares not exercised, if any. Payment of such purchase price shall be made by check payable to the order of the Corporation. The certificate or certificates for the shares as to which the
Option shall have been so exercised shall be registered in the name of the person or persons so exercising the Option (or, if the Option shall be exercised by the Grantee and if the Grantee shall so request in the notice exercising the Option, shall be
registered in the name of the Grantee and another person jointly, with right of survivorship) and shall be delivered as provided above to or upon the written order of the person or persons exercising the Option. In the event the Option shall be exercised,
pursuant to paragraph 5 hereof, by any person or persons other than the Grantee, such notice shall be accompanied by 

2

appropriate proof of the right of such person or persons to exercise the Option. All shares that shall be purchased upon the exercise of the Option as provided herein shall be fully paid and nonassessable. 

9.

Subsidiary.  As used herein, the term "subsidiary" shall mean any present or future corporation which would be a "subsidiary corporation" of the
Corporation, as that term is defined in Section 424 of the Internal Revenue Code of 1986. 

10.

Withholding. As a condition to the issuance of shares of Common Stock of the Corporation under this Option, the Grantee authorizes the Corporation to withhold in accordance
with applicable law any taxes required to be withheld by the Corporation under Federal, State or local law as a result of his exercise of this Option.

11.

Information. The Grantee acknowledges and represents that he has reviewed all financial and other records of the Corporation that he deems necessary to make an informed
decision about the Corporation’s future prospects and the value of this Option.

GREENWAY MEDICAL TECHNOLOGIES, INC.

By:__________________________

 

Its:

 

____________________________

[________], Grantee

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00193-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00193-of-00352.parquet"}]]